Results of a pharmacoeconomic analysis of the rationality of the use of acute myeloid leukemia chemotherapy regimens with the use of various doses of cytarabine

Results of a pharmacoeconomic analysis of the rationality of the use of acute myeloid leukemia chemotherapy regimens with the use of various doses of cytarabine

A pharmacoeconomic study of the rationality of the use of various chemotherapy regimens (“7 + 3” scheme) in the treatment of patients with acute forms of myeloid leukemia has been carried out. The use of the chemotherapy regimen “7 + 3” with 200 mg / m2 / per day dosage of cytarabine on 1-7 days all...

Full description

Bibliographic Details
Main Authors: Panfilova Hanna, Goncharova Anastasiya, Korzh Iuliia, Zhirova Irina, Tsurikova Oksana, Bezuglaia Natalia
Format: Article
Language:English
Published: EDP Sciences 2021-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/full_html/2021/02/bioconf_ils2021_03003/bioconf_ils2021_03003.html

Similar Items

Similar Items